跳至主要内容
临床试验/CTRI/2014/05/004630
CTRI/2014/05/004630尚未招募未知

A multicenter registry of pulmonary arterial hypertension in India - PAH Registry

Cipla Ltd0 个研究点目标入组 150 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
Cipla Ltd
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1.Written, signed, dated and ethics committee approved data sharing consent obtained from patients before performing any procedures.
  • 2.Newly diagnosed or previously diagnosed patients with Group I PAH.

排除标准

  • 1.Patients who meet the criteria for inclusion into Groups II, III, IV or V
  • 2.Do not meet the required hemodynamic criteria for entry into the study when right heart catheterization data is available.

研究者

发起方
Cipla Ltd

相似试验